Lopinavir/Ritonavir Viatris [Mylan]

Medicinal product

(Invented) name

Lopinavir/Ritonavir Viatris [Mylan]

Active substance (s)

Lopinaviras/Ritonaviras

Strength

200 mg/50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AR10, Lopinavir and ritonavir

Marketing authorisation holder

Viatris Limited, Airija

Date of authorisation

2016-01-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Lopinaviras	200 mg
Ritonaviras	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65210	79711	1079711	lizdinė plokštelė	N120		Receptinis	EU/1/15/1067/004	Netiekiama	-	-	No	-	-
65211	79712	1079712	lizdinė plokštelė	N360		Receptinis	EU/1/15/1067/005	Netiekiama	-	-	No	-	-
65212	79713	1079713	dalomoji lizdinė plokštelė	N120x1		Receptinis	EU/1/15/1067/006	Netiekiama	-	-	No	-	-
65213	79714	1079714	buteliukas	N360 (3x120)		Receptinis	EU/1/15/1067/007	Netiekiama	-	-	No	-	-
65214	79715	1079715	buteliukas	N120		Receptinis	EU/1/15/1067/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-01-14	Registruotas